Regulation of CDK4

被引:61
|
作者
Bockstaele, Laurence [1 ]
Coulonval, Katia [1 ]
Kooken, Hugues [1 ]
Paternot, Sabine [1 ]
Roger, Pierre P. [1 ]
机构
[1] Univ Libre Bruxelles, Fac Med, Inst Interdisciplinary Res IRIBHM, B-1070 Brussels, Belgium
关键词
Nuclear Import; T98G Cell; CDK4 Activity; Master Integrator; Mitogenic Stimulation;
D O I
10.1186/1747-1028-1-25
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cyclin-dependent kinase (CDK)4 is a master integrator that couples mitogenic and antimitogenic extracellular signals with the cell cycle. It is also crucial for many oncogenic transformation processes. In this overview, we address various molecular features of CDK4 activation that are critical but remain poorly known or debated, including the regulation of its association with D-type cyclins, its subcellular location, its activating Thr172-phosphorylation and the roles of Cip/Kip CDK "inhibitors" in these processes. We have recently identified the T-loop phosphorylation of CDK4, but not of CDK6, as a determining target for cell cycle control by extracellular factors, indicating that CDK4-activating kinase(s) might have to be reconsidered.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Dissecting the role of CDK4 in liposarcoma
    Vanni, Silvia
    Gallo, Graziana
    Fausti, Valentina
    Miserocchi, Giacomo
    Liverani, Chiara
    Spadazzi, Chiara
    Cocchi, Claudia
    Calabrese, Chiara
    De Luca, Giovanni
    Bassi, Massimo
    Gessaroli, Manlio
    Campobassi, Angelo
    Pieri, Federica
    Ercolani, Giorgio
    Cavaliere, Davide
    Gurrieri, Lorena
    Riva, Nada
    Martinelli, Giovanni
    Mercatali, Laura
    De Vita, Alessandro
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Amplification of the cyclin-dependent kinase 4 (CDK4) gene and CDK4 overexpression in a subgroup of pancreatic carcinomas
    Bartsch, D
    Barth, P
    Arnold, R
    Simon, B
    GASTROENTEROLOGY, 1999, 116 (04) : A1164 - A1164
  • [33] cdk4 gene amplification in neuroblastoma
    Gereke, H
    Anderer, U
    Dietel, M
    Hagemeier, C
    CANCER GENE THERAPY, 1997, 4 (05) : 302 - 302
  • [34] Preclinical head-to-head comparison of CDK4/6 inhibitor activity toward CDK4 vs CDK6
    Delach, Scott
    Caponigro, Giordano
    CANCER RESEARCH, 2021, 81 (04)
  • [35] Mice thrive without Cdk4 and Cdk2
    Barriere, Cedric
    Santamaria, David
    Cerqueira, Antonio
    Galan, Javier
    Martin, Alberto
    Ortega, Sagrario
    Malumbres, Marcos
    Dubus, Pierre
    Barbacid, Mariano
    MOLECULAR ONCOLOGY, 2007, 1 (01): : 72 - 83
  • [36] Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs
    Green, Jennifer L.
    Okerberg, Eric S.
    Sejd, Josilyn
    Palafox, Marta
    Monserrat, Laia
    Alemayehu, Senait
    Wu, Jiangyue
    Sykes, Maria
    Aban, Arwin
    Serra, Violeta
    Nomanbhoy, Tyzoon
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) : 771 - 779
  • [37] Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition
    Paternot, Sabine
    Raspe, Eric
    Meiller, Clement
    Tarabichi, Maxime
    Assie, Jean-Baptiste
    Libert, Frederick
    Remmelink, Myriam
    Bisteau, Xavier
    Pauwels, Patrick
    Blum, Yuna
    Le Stang, Nolwenn
    Tabone-Eglinger, Severine
    Galateau-Salle, Francoise
    Blanquart, Christophe
    Van Meerbeeck, Jan P.
    Berghmans, Thierry
    Jean, Didier
    Roger, Pierre P.
    MOLECULAR ONCOLOGY, 2024, 18 (04) : 866 - 894
  • [38] Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
    Perez, Marco
    Munoz-Galvan, Sandra
    Jimenez-Garcia, Manuel P.
    Marin, Juan J.
    Carnero, Amancio
    ONCOTARGET, 2015, 6 (38) : 40557 - 40574
  • [39] Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein
    Ikuta, M
    Kamata, K
    Fukasawa, K
    Honma, T
    Machida, T
    Hirai, H
    Suzuki-Takahashi, I
    Hayama, T
    Nishimura, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 27548 - 27554
  • [40] PROTACs suppression of CDK4/6, crucial kinases for cell cycle regulation in cancer
    Zhao, Bosheng
    Burgess, Kevin
    CHEMICAL COMMUNICATIONS, 2019, 55 (18) : 2704 - 2707